Allarity Therapeutics ALLR
NASDAQ ALLR
$0.90 +0.03 (+3.18%)
As of: Oct 21, 2026 · 11:12 AM EDT

Allarity Therapeutics (ALLR) Operating Leases (2020 - 2021)

Updated

Allarity Therapeutics (ALLR) reported Operating Leases of $9,000 for Q4 2021, down 96.6% from $267,000 a year earlier and down 74.3% from the prior quarter.

Analysis

Allarity Therapeutics (ALLR) Operating Leases (2020 - 2021) Analysis & Trends

  • By year, Operating Leases came in at $267,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Allarity Therapeutics 14.36 Mn -54.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 9,000.00
Sep 30, 2021 35,000.00
Dec 31, 2020 267,000.00
API Access

Allarity Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ALLR&period=max&api_key=YOUR_API_KEY